Attitudes on Prophylactic Antibiotic Use in Dermatologic Surgery: A Survey Study of American College of Mohs Surgery Members.

Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9504371 Publication Model: Print Cited Medium: Internet ISSN: 1524-4725 (Electronic) Linking ISSN: 10760512 NLM ISO Abbreviation: Dermatol Surg Subsets: MEDLINE

Publication: 2021- : [Philadelphia] : Wolters Kluwer Health
Original Publication: New York, NY : Elsevier Science, c1995-

Antibiotic Prophylaxis* ; Attitude of Health Personnel* ; Dermatologic Surgical Procedures*/adverse effects ; Practice Patterns, Physicians'*; Dermatologists/*psychology ; Surgical Wound Infection/*prevention & control; Cross-Sectional Studies ; Health Care Surveys ; Humans ; Mohs Surgery ; Societies, Medical ; United States

Background: Antibiotic prescriptions associated with dermatologic surgical visits are increasing and prescribing practices vary among surgeons.
Objective: To describe dermatologic surgeons' attitudes and practices regarding prophylactic antibiotic use for surgical site infection (SSI), to compare current prescribing practices to those of a 2012 survey, and to determine surgeons' interest in clinical trial data on the utility of prophylactic antibiotics.
Materials and Methods: This was a cross-sectional online survey of the American College of Mohs Surgery (ACMS) members. Survey items were adapted from a 2012 survey of ACMS members.
Results: The survey was initiated by 101 ACMS members. 75.25% (76/101) of surgeons reported routinely prescribing prophylactic antibiotics to reduce SSI risk. The use of prophylactic antibiotics varied with clinical scenario. Most providers (84.21%, 64/76) prescribe postoperative antibiotics, with an average course of 6.56 days. 40.21% (39/97) of respondents were uncertain if prophylaxis prevents SSI, and up to 90.63% (87/96) indicated interest in clinical trial data evaluating the efficacy of oral antibiotics for SSI prevention.
Conclusion: Dermatologic surgeons continue to report varied attitudes and practices for SSI prophylaxis. Evidence from clinical trials is desired by surgeons to guide clinical practice.
(Copyright © 2020 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)

Centers for Disease Control and Prevention. Outpatient Antibiotic Prescriptions: United States, 2015. Available at: https://www.cdc.gov/antibiotic-use/community/programs-measurement/state-local-activities/outpatient-antibiotic-prescriptions-US-2015.html. Accessed November 1, 2019.
Barbieri JS, Bhate K, Hartnett KP, Fleming-Dutra KE, et al. Trends in oral antibiotic prescription in dermatology, 2008 to 2016. JAMA Dermatol 2019;155:290–7.
Affleck AG, Birnie AJ, Gee TM, Gee BC. Antibiotic prophylaxis in patients with valvular heart defects undergoing dermatological surgery remains a confusing issue despite apparently clear guidelines. Clin Exp Dermatol 2005;30:487–9.
Scheinfeld N, Struach S, Ross B. Antibiotic prophylaxis guideline awareness and antibiotic prophylaxis use among New York State dermatologic surgeons. Dermatol Surg 2002;28:841–4.
Bae-Harboe YS, Liang CA. Perioperative antibiotic use of dermatologic surgeons in 2012. Dermatol Surg 2013;39:1592–601.
Barbieri JS, Etzkorn JR, Margolis DJ. Use of antibiotics for dermatologic procedures from 2008 to 2016. JAMA Dermatol 2019;155:465–70.
Barbieri JS, Fix WC, Miller CJ, Sobanko JF, et al. Variation in prescribing and factors associated with the use of prophylactic antibiotics for Mohs surgery: a single-institution retrospective study. Dermatol Surg 2019;46:868–75.
Singh P, Mostaghimi A, Barbieri JS. Antibiotic utilization in Medicare beneficiaries receiving Mohs micrographic surgery. J Am Acad Dermatol 2020. S0190-9622(20)30229-2. doi: 10.1016/j.jaad.2020.02.021. S0190-9622(20)30229-2. doi: 10.1016/j.jaad.2020.02.021. (PMID: 10.1016/j.jaad.2020.02.021)
Dantes R, Mu Y, Hicks LA, Cohen J, et al. Association between outpatient antibiotic prescribing practices and community-associated Clostridium difficile infection. Open Forum Infect Dis 2015;2:ofv113.
Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008;47:735–43.
Wright TI, Baddour LM, Berbari EF, Roenigk RK, et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol 2008;59:464–73.
Maher JW, Conklin J, Heitshusen DS. Thoracoscopic esophagomyotomy for achalasia: preoperative patterns of acid reflux and long-term follow-up. Surgery 2001;130:570–6; discussion 576-577.
American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys Web Site. 2016. Available at: https://www.aapor.org/AAPOR_Main/media/publications/Standard-Definitions20169theditionfinal.pdf. Accessed April 20, 2020.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59:e10–52.
Web Appendix 25, Summary of a systematic review on surgical antibiotic prophylaxis prolongation. In: Global Guidelines for the Prevention of Surgical Site Infection. Geneva, Switzerland: World Health Organization; 2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK536429/. Accessed January 15, 2020.
Zhang Y, Dong J, Qiao Y, He J, et al. Efficacy and safety profile of antibiotic prophylaxis usage in clean and clean-contaminated plastic and reconstructive surgery: a meta-analysis of randomized controlled trials. Ann Plast Surg 2014;72:121–30.
Lin MH, Pan SC, Wang JL, Hsu RB, et al. Prospective randomized study of efficacy of 1-day versus 3-day antibiotic prophylaxis for preventing surgical site infection after coronary artery bypass graft. J Formos Med Assoc 2011;110:619–26.
Smith H, Borchard K, Cherian P, Tai Y, et al. Randomized controlled trial of preoperative topical decolonization to reduce surgical site infection for Staphylococcus aureus nasal swab-negative Mohs micrographic surgery patients. Dermatol Surg 2019;45:229–33.

Date Created: 20200908 Date Completed: 20210817 Latest Revision: 20210817

20221213

10.1097/DSS.0000000000002676

32897951